H.J.T. Rutten

ORCID: 0000-0003-2532-950X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Anorectal Disease Treatments and Outcomes
  • Genetic factors in colorectal cancer
  • Cardiac, Anesthesia and Surgical Outcomes
  • Breast Cancer Treatment Studies
  • Intraperitoneal and Appendiceal Malignancies
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Lesions and Carcinomas
  • Enhanced Recovery After Surgery
  • Stoma care and complications
  • Hernia repair and management
  • Appendicitis Diagnosis and Management
  • Clinical practice guidelines implementation
  • Nutrition and Health in Aging
  • Breast Implant and Reconstruction
  • Frailty in Older Adults
  • Esophageal Cancer Research and Treatment
  • Advanced Radiotherapy Techniques
  • Pelvic floor disorders treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Ovarian cancer diagnosis and treatment

Radboud University Nijmegen
2016-2025

Maastricht University
2016-2025

Catharina Ziekenhuis
2016-2025

Amsterdam University Medical Centers
2024

University of Amsterdam
2024

Cancer Center Amsterdam
2024

Southampton General Hospital
2023

University of Southampton
2023

PAMM
2021

Leiden University Medical Center
2004-2020

Short-term preoperative radiotherapy and total mesorectal excision have each been shown to improve local control of disease in patients with resectable rectal cancer. We conducted a multicenter, randomized trial determine whether the addition increases benefit excision.We randomly assigned 1861 cancer either (5 Gy on five days) followed by (924 patients) or alone (937 patients). The was use standardization quality-control measures ensure consistency radiotherapy, surgery, pathological...

10.1056/nejmoa010580 article EN New England Journal of Medicine 2001-08-30

In Brief Objective: To investigate the efficacy of preoperative short-term radiotherapy in patients with mobile rectal cancer undergoing total mesorectal excision (TME) surgery. Summary Background Data: Local recurrence is a major problem treatment. Preoperative has shown to improve local control and survival combination conventional The TME trial investigated value this regimen excision. Long-term results are reported after median follow-up 6 years. Methods: One thousand eight hundred...

10.1097/01.sla.0000257358.56863.ce article EN Annals of Surgery 2007-11-01

Preoperative short-term radiotherapy improves local control in patients treated with total mesorectal excision (TME). This study was performed to assess the presence and magnitude of long-term side effects preoperative 5 x Gy TME. Also, hospital treatment recorded for diseases possibly related late rectal cancer treatment.Long-term morbidity assessed from prospective randomized TME trial, which investigated efficacy before surgery mobile cancer. Dutch without recurrent disease were sent a...

10.1200/jco.2005.14.779 article EN Journal of Clinical Oncology 2005-08-31

Abstract Background Anastomotic leakage is a major complication of rectal cancer surgery. The aim this study was to investigate risk factors associated with symptomatic anastomotic after total mesorectal excision (TME). Methods Between 1996 and 1999, patients operable were randomized receive short-term radiotherapy followed by TME or undergo alone. Eligible Dutch who underwent an anterior resection (924 patients) studied retrospectively. Results Symptomatic occurred in 107 (11·6 per cent)....

10.1002/bjs.4806 article EN British journal of surgery 2004-12-06

Few prospective studies have been performed about the impact of preoperative radiotherapy (PRT) or total mesorectal excision (TME) on health-related quality life (HRQL) and sexual functioning in patients with resectable rectal cancer. This report describes HRQL 990 who underwent TME were randomly assigned to short-term PRT (5 x 5 Gy).The Rotterdam Symptom Check List supplemented additional items was used questionnaires before treatment at 3, 6, 12, 18, 24 months after surgery. Patients...

10.1200/jco.2005.05.256 article EN Journal of Clinical Oncology 2005-03-18

Improvements in magnetic resonance imaging (MRI), total mesorectal excision (TME) surgery, and the use of (chemo)radiotherapy ([C]RT) have improved local control rectal cancer; however, we been unable to eradicate recurrence (LR). Even face TME negative resection margins (R0), a significant proportion patients with enlarged lateral lymph nodes (LLNs) suffer from LR (LLR). Japanese studies suggest that addition an LLN dissection (LLND) could reduce LLR. This multicenter pooled analysis aims...

10.1200/jco.18.00032 article EN Journal of Clinical Oncology 2018-11-07

The aim of our study was to provide population-based data on incidence and prognosis synchronous peritoneal carcinomatosis evaluate predictors for its development. Diagnosed in 1995-2008, 18,738 cases primary colorectal cancer were included. Predictors analysed by multivariable logistic regression analysis. Median survival months calculated site metastasis. In the period, 904 patients diagnosed with (4.8% total, constituting 24% presenting M1 disease). risk increased case advanced T stage...

10.1002/ijc.25596 article EN International Journal of Cancer 2010-08-16

Consensus abstract Background The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent (RRC) is challenging. There global variation in standards no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, conventional planes. aim the Beyond TME Group was to consensus on definitions principles management, identify areas research priority. Methods Delphi methodology used consensus. consisted invited...

10.1002/bjs.9192_1 article EN British journal of surgery 2013-06-21

Previously, it was shown in patients with low rectal cancer that a short-axis (SA) lateral node size of 7 mm or greater on primary magnetic resonance imaging (MRI) resulted high local recurrence (LLR) rate after chemoradiotherapy radiotherapy ([C]RT) total mesorectal excision (TME) and this risk lowered by lymph dissection (LLND). The role restaging MRI (C)RT regard to LLR which specific might benefit from an LLND is not fully understood.To determine the factors are associated formulate...

10.1001/jamasurg.2019.2172 article EN JAMA Surgery 2019-07-03

Consensus abstract Background The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent (RRC) is challenging. There global variation in standards no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, conventional planes. aim the Beyond TME Group was to consensus on definitions principles management, identify areas research priority. Methods Delphi methodology used consensus. consisted invited...

10.1002/bjs.9192 article EN British journal of surgery 2013-06-10

Abstract Background This prospective multicentre study was performed to quantify the number of patients with minimal residual disease (ypT0–1) after neoadjuvant chemoradiotherapy and transanal endoscopic microsurgery (TEM) for rectal cancer. Methods Patients clinically staged T1–3 N0 distal cancer were treated long-course chemoradiotherapy. Clinical response evaluated 6–8 weeks later TEM performed. Total mesorectal excision advocated in (ypT2 or more). Results The clinical stage cT1 ten...

10.1002/bjs.9809 article EN British journal of surgery 2015-04-02

Abstract Background Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variable outcomes, the majority of data from single-centre series. This study analysed an international collaboration to determine robust parameters that could inform clinical decision-making. Methods Anonymized on patients who had pelvic LRRC between 2004 and 2014 were accrued 27 specialist centres. The primary endpoint was survival. impact resection margin, bone resection, node status use...

10.1002/bjs.10734 article EN British journal of surgery 2018-03-12
Laura M. Fernández Guilherme Pagin São Julião Nuno Figueiredo Geerard L. Beets Maxime J.M. van der Valk and 94 more Renu R. Bahadoer Denise E. Hilling Elma Meershoek‐Klein Kranenbarg Annet G.H. Roodvoets Andrew G. Renehan Cornelis J.�H. van de Velde Angelita Habr‐Gama Rodrigo Oliva Perez Ayman S. Abdelrazeq Oktar Asoğlu Rita Barroca Joy M. Beveridge Anup Kumar Bhowmick Anthony Blower Mike Braun Krzysztof Bujko P. Carter Carlos Carvalho Claudio Coco Chris Cunningham André D’Hoore Gabriel Dimofte Peirong Ding S. Duff Sharnie Dwyer Jonathan I. Epstein Daniel D. Evans Paul Fulford Wolfgang B. Gaertner Jean‐Pierre Gérard Simon Gollins Ryan A. Harris Ewen M. Harrison J. Heat J. Hill J Hobbiss Eduardo Huertas Zahirul Huq Soledad Iseas Anders Jakobsen Derek A. Jones Leslie S. Jones Uzair Ali Khan RS Kushwaha Nicholas P. Lees TY Linn S Loganathan Fernando López‐Campos Robert D. Madoff З. З. Мамедли Anna Martling Klaus E. Matzel Jarno Melenhorst Philip B. Mitchell Sthela Maria Murad‐Regadas Sarah O’Dwyer Alejandro Pairola Marius Paraoan Oriol Parés Koen Peeters S H Pettit N Pranesh R Rajaganeshan Srinivasan Ravi Shyamji Rawat David M. Richards K Riyad Gustavo Rossi H.J.T. Rutten M. Saeed J.R. Salaman Fernando Sánchez Loria Marit E. van der Sande Inês Santiago Chelliah Selvasekar K.H. Siddiqui Christopher J. Smart Mamoon Solkar Arthur Sun Myint Bruce Taylor Karen Telford Nigel Scott Carlos Vaccaro Bruna Borba Vailati C Verberne Pedro Vieira Dale Vimalchandran Sarah V. Ward Malcolm Wilson D. C. Winter Carlijn Witjes Albert Wolthuis Jing Zhang Zhen Zhang

10.1016/s1470-2045(20)30557-x article EN The Lancet Oncology 2020-12-13
Coming Soon ...